Summary:
Do you have lung cancer?
Boehringer Ingelheim Biosimilar Study 1302.5 is looking for patients to help research a potential new treatment option for non-small cell lung cancer.
You may be able to participate in the study if you:
- are 18 years of age or older
- have been diagnosed with recurrent or metastatic nonsquamous non-small cell lung cancer (which means that the cancer has come back after treatment, or has spread from the lungs to other areas of the body)
- have not yet received treatment for metastatic cancer